PHARMAFARM secures contract for Framework Agreement Medicines used in Cardiology, Antineoplastic, Medicam for digestive tract and metabolism, Medicam impotes obstructive diseases of the airways

MLA

“PHARMAFARM Secures Contract for Framework Agreement Medicines Used in Cardiology, Antineoplastic, Medicam for Digestive Tract and Metabolism, Medicam Impotes Obstructive Diseases of the Airways.” Pivotal Sources, 27 Jan. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.690677470&authtype=sso&custid=ns315887.

APA

PHARMAFARM secures contract for Framework Agreement Medicines used in Cardiology, Antineoplastic, Medicam for digestive tract and metabolism, Medicam impotes obstructive diseases of the airways. (2022, January 27). Pivotal Sources.

Chicago

Pivotal Sources. 2022. “PHARMAFARM Secures Contract for Framework Agreement Medicines Used in Cardiology, Antineoplastic, Medicam for Digestive Tract and Metabolism, Medicam Impotes Obstructive Diseases of the Airways,” January 27. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.690677470&authtype=sso&custid=ns315887.